23-Jan-2026
No press releases found.
Healthcare debate should focus on out-of-pocket costs, not list prices – Novartis CEO
Seeking Alpha News (Thu, 22-Jan 1:04 PM ET)
The Fund invests at least 80% of its net assets in equity securities of companies that are relevant to the Fund s investment theme of genomic advancements. The Fund invests predominantly in common stock. The Fund s investment theme of genomic advancements are those that the investment manager believes are substantially focused on and/or are expected to substantially benefit from extending and enhancing the quality of human and other life (e.g., animals) by incorporating technological and scientific developments, improvements and advancements in the field of genomics into their business, such as by offering new products or services that rely on genetic engineering, gene therapy, genome analysis, DNA sequencing, synthesis or instrumentation. These companies may include those that research, develop, produce, manufacture or significantly rely on or enable bionic devices, bio-inspired computing, bioinformatics, molecular medicine and diagnostics, pharmaceuticals and agricultural applications of genomics, and related equipment, techniques and processes.
Franklin Genomic Advancements ETF trades on the BATS stock market under the symbol HELX.
As of January 23, 2026, HELX stock price declined to $37.36 with 422 million shares trading.
HELX has a market cap of $24.28 million. This is considered a Sub-Micro Cap stock.
In the last 3 years, HELX traded as high as $38.17 and as low as $23.74.
HELX has outperformed the market in the last year with a price return of +22.1% while the SPY ETF gained +14.2%. HELX has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +10.8% and -0.1%, respectively, while the SPY returned +2.9% and -0.7%, respectively.
HELX support price is $37.64 and resistance is $38.57 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that HELX shares will trade within this expected range on the day.
